Mitochondrial respiration in muscle and liver from cold-acclimated hypothyroid rats.
The effects of long-term cold exposure on muscle and liver mitochondrial oxygen consumption in hypothyroid and normal rats were examined. Thyroid ablation was performed after 8-wk acclimation to 4 degrees C. Hypothyroid and normal controls remained in the cold for an additional 8 wk. At the end of 16-wk cold exposure, all hypothyroid rats were alive and normothermic and had normal body weight. At ambient temperature (24 degrees C), thyroid ablation induced a 65% fall in muscle mitochondrial oxygen consumption, which was reversed by thyroxine but not by norepinephrine administration. After cold acclimation was reached, suppression of thyroid function reduced muscle mitochondrial respiration by 30%, but the hypothyroid values remained about threefold higher than those in hypothyroid muscle in the warm. Blockade of beta- and alpha1-adrenergic receptors in both hypothyroid and normal rats produced hypothermia in vivo and a fall in muscle, liver, and brown adipose tissue mitochondria respiration in vitro. In normal rats, cold acclimation enhanced muscle respiration by 35%, in liver 18%, and in brown adipose tissue 450% over values in the warm. The results demonstrate that thyroid hormones, in the presence of norepinephrine, are major determinants of thermogenic activity in muscle and liver of cold-acclimated rats. After thyroid ablation, cold-induced nonshivering thermogenesis replaced 3,5,3'-triiodothyronine-induced thermogenesis, and normal body temperature was maintained.
Zaninovich
Angel A
AA
Hospital de Clínicas, Nuclear Medicine Center, Av. Córdoba 2351, 1120 Buenos Aires, Argentina. azaninovich@sinectis.com.ar
Rebagliati
Ines
I
Raices
Marcela
M
Ricci
Conrado
C
Hagmuller
Karl
K
D002001:Adipose Tissue, Brown / Q000378:metabolism; D018674:Adrenergic Antagonists / Q000494:pharmacology; D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D001835:Body Weight; D003080:Cold Temperature; D004338:Drug Combinations; D005260:Female; D007037:Hypothyroidism / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism*; D008931:Mitochondria, Muscle / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011224:Prazosin / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012110:Reserpine / Q000494:pharmacology; D013696:Temperature; D022722:Thermogenesis / Q000187:drug effects
D018674:Adrenergic Antagonists; D018759:Adrenergic Uptake Inhibitors; D004338:Drug Combinations; D012110:Reserpine; D011433:Propranolol; D009638:Norepinephrine; D011224:Prazosin